MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a significant player in the medical device industry, has announced the award of restricted stock units (RSUs) to eleven new employees as part of their employment packages. The grants, approved by the company’s Compensation Committee on May 6, 2024, encompass 20,250 shares of common stock, aligning with Nasdaq Rule 5635(c)(4) for inducement grants.
These RSUs are designed to vest over a four-year period, provided the recipients remain employed with TELA Bio through each vesting milestone. This move highlights TELA Bio’s commitment to attracting top talent by integrating equity-based incentives into its compensation strategy, marking a strategic effort to ensure the long-term engagement and loyalty of its workforce.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.